Menu
Search
|

Menu

Close
X

China Biologic Products Holdings Inc CBPO.OQ (NASDAQ Stock Exchange Global Select Market)

70.50 USD
-- (--)
As of Oct 22
chart
Previous Close 70.50
Open --
Volume --
3m Avg Volume 127,684
Today’s High --
Today’s Low --
52 Week High 107.32
52 Week Low 70.04
Shares Outstanding (mil) 37.27
Market Capitalization (mil) 2,897.00
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.38 Mean rating from 8 analysts

KEY STATS

Revenue (mm, USD)
FY18
233
FY17
271
FY16
341
FY15
296
EPS (USD)
FY18
1.806
FY17
2.715
FY16
3.737
FY15
3.298
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.14
Price to Sales (TTM)
vs sector
--
6.55
Price to Book (MRQ)
vs sector
2.34
4.00
Price to Cash Flow (TTM)
vs sector
--
21.51
Total Debt to Equity (MRQ)
vs sector
0.00
14.15
LT Debt to Equity (MRQ)
vs sector
0.00
11.31
Return on Investment (TTM)
vs sector
--
12.83
Return on Equity (TTM)
vs sector
--
14.95

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

BEIJING   BEJ   100125

Phone: +8610.65983111

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

SPONSORED STORIES